183 related articles for article (PubMed ID: 30266752)
21. Combination of integrin siRNA and irradiation for breast cancer therapy.
Cao Q; Cai W; Li T; Yang Y; Chen K; Xing L; Chen X
Biochem Biophys Res Commun; 2006 Dec; 351(3):726-32. PubMed ID: 17087916
[TBL] [Abstract][Full Text] [Related]
22. PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells.
Symonds JM; Ohm AM; Tan AC; Reyland ME
Oncotarget; 2016 Apr; 7(14):17905-19. PubMed ID: 26918447
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells.
Mao A; Zhao Q; Zhou X; Sun C; Si J; Zhou R; Gan L; Zhang H
Sci Rep; 2016 Jun; 6():27346. PubMed ID: 27250340
[TBL] [Abstract][Full Text] [Related]
24. Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1 alpha and survivin in U87 cells.
Lanvin O; Monferran S; Delmas C; Couderc B; Toulas C; Cohen-Jonathan-Moyal E
Eur J Cancer; 2013 Sep; 49(13):2884-91. PubMed ID: 23747271
[TBL] [Abstract][Full Text] [Related]
25. Activation of tumor cell integrin αvβ3 by radiation and reversal of activation by chemically modified tetraiodothyroacetic acid (tetrac).
Leith JT; Hercbergs A; Kenney S; Mousa SA; Davis PJ
Endocr Res; 2018 Nov; 43(4):215-219. PubMed ID: 29611723
[TBL] [Abstract][Full Text] [Related]
26. Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.
Stachurska A; Elbanowski J; Kowalczyńska HM
Cell Biol Int; 2012 Oct; 36(10):883-92. PubMed ID: 22686483
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
Bae YJ; Yoon YI; Yoon TJ; Lee HJ
Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3.
Parra E; Ortega A; Saenz L
Oncol Rep; 2009 Dec; 22(6):1513-8. PubMed ID: 19885607
[TBL] [Abstract][Full Text] [Related]
30. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
Yang W; Sun T; Cao J; Liu F
Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
[TBL] [Abstract][Full Text] [Related]
31. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.
Rosser CJ; Tanaka M; Pisters LL; Tanaka N; Levy LB; Hoover DC; Grossman HB; McDonnell TJ; Kuban DA; Meyn RE
Cancer Gene Ther; 2004 Apr; 11(4):273-9. PubMed ID: 14765130
[TBL] [Abstract][Full Text] [Related]
32. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
Chen W; Liu Y; Chen H; Ning H; Ding K
Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
[TBL] [Abstract][Full Text] [Related]
33. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
34. Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer.
Gupta S; Ahmed MM
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1553. PubMed ID: 34533293
[TBL] [Abstract][Full Text] [Related]
35. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
Zhang M; Latham DE; Delaney MA; Chakravarti A
Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
[TBL] [Abstract][Full Text] [Related]
36. Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
Testa A; Quaglia F; Naranjo NM; Verrillo CE; Shields CD; Lin S; Pickles MW; Hamza DF; Von Schalscha T; Cheresh DA; Leiby B; Liu Q; Ding J; Kelly WK; Hooper DC; Corey E; Plow EF; Altieri DC; Languino LR
Matrix Biol; 2023 Dec; 124():49-62. PubMed ID: 37956856
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
[TBL] [Abstract][Full Text] [Related]
38. RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating α(v)β₃ expression.
Xu W; Luo T; Li P; Zhou C; Cui D; Pang B; Ren Q; Fu S
Int J Nanomedicine; 2012; 7():915-24. PubMed ID: 22412298
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV
Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035
[TBL] [Abstract][Full Text] [Related]
40. Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells.
Wang R; Qi B; Dong YW; Cai QQ; Deng NH; Chen Q; Li C; Jin YT; Wu XZ
Oncotarget; 2016 Jun; 7(24):36563-36576. PubMed ID: 27145276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
